Related Experiment Videos
OBSL1 mutations in 3-M syndrome are associated with a modulation of IGFBP2 and IGFBP5 expression levels
Celine Huber1, Mélanie Fradin, Thomas Edouard
1University Paris Descartes, Department of Genetics and INSERM U781, Hospital Necker Enfants-Malades, Paris, France.
Abstract:
3-M syndrome is an autosomal recessive disorder characterized by severe pre- and postnatal growth retardation and minor skeletal changes. We have previously identified CUL7 as a disease-causing gene but we have also provided evidence of genetic heterogeneity in the 3-M syndrome. By homozygosity mapping in two inbred families, we found a second disease locus on chromosome 2q35-36.1 in a 5.2-Mb interval that encompasses 60 genes. To select candidate genes, we performed microarray analysis of cultured skin fibroblast RNA from one patient, looking for genes with altered expression; we found decreased expression of IGFBP2 and increased expression of IGFBP5. However, direct sequencing of these two genes failed to detect any anomaly. We then considered other candidate genes by their function/location and found nine distinct mutations in the OBSL1 gene in 13 families including eight nonsense and one missense mutations. To further understand the links between OBSL1, CUL7, and insulin-like growth factor binding proteins (IGFBPs), we performed real-time quantitative PCR (RT-PCR) analysis for OBSL1, CUL7, IGFBP2, and IGFBP5, using cultured fibroblast RNAs from two patients with distinct OBSL1 mutations (p.F697G; p.H814RfsX15). We found normal CUL7 mRNA levels but abnormal IGFBP2 and IGFBP5 mRNA levels in the two patients, suggesting that OBSL1 modulates the expression of IGFBP proteins.
Insights
3-M syndrome, a growth disorder, is linked to OBSL1 gene mutations. These mutations affect IGFBP2 and IGFBP5 expression, suggesting OBSL1
Area of Science:
- Genetics and Molecular Biology
- Endocrinology
- Skeletal Dysplasias
Background:
- 3-M syndrome is an autosomal recessive disorder causing severe growth retardation.
- Genetic heterogeneity exists, with CUL7 previously identified as a disease gene.
- Previous studies suggested other genetic factors contribute to 3-M syndrome.
Purpose of the Study:
- To identify the second disease locus for 3-M syndrome.
- To investigate the role of OBSL1 gene in 3-M syndrome pathogenesis.
- To explore the relationship between OBSL1, CUL7, and insulin-like growth factor binding proteins (IGFBPs).
Main Methods:
- Homozygosity mapping to identify a novel disease locus on chromosome 2q35-36.1.
- Microarray analysis of fibroblast RNA to identify differentially expressed genes.
- Direct sequencing of candidate genes and mutation analysis of OBSL1.
- Real-time quantitative PCR (RT-PCR) to assess mRNA levels of OBSL1, CUL7, IGFBP2, and IGFBP5.
Main Results:
- A second locus for 3-M syndrome was mapped to chromosome 2q35-36.1.
- Nine distinct mutations were identified in the OBSL1 gene in 13 families.
- OBSL1 mutations led to abnormal mRNA levels of IGFBP2 and IGFBP5, but not CUL7.
- Patients with OBSL1 mutations showed altered IGFBP2 and IGFBP5 expression.
Conclusions:
- OBSL1 is a second major gene involved in 3-M syndrome.
- OBSL1 mutations disrupt the expression of IGFBP2 and IGFBP5.
- OBSL1 likely modulates IGFBP protein expression, contributing to growth retardation in 3-M syndrome.
Related Concept Videos
TGF - β Signaling Pathway
Abnormal Proliferation
RNA Splicing
Hedgehog Signaling Pathway
Pleiotropy